#coronary vasomotion

[gwmac]

10 Surprising Health Benefits of Eating Dark Chocolate

Introduction: Dark chocolate is not only a tasty treat, but it also has a variety of health benefits that may surprise you. From improving heart health to boosting brain function, there are many reasons to indulge in a bit of dark chocolate every day. In this article, we’ll explore the top 10 health benefits of dark chocolate, backed by scientific research and expert opinions. Top 10 Benefits of…

[tmr-research]

Coronary Stent Market Predicted to Accelerate the Growth by 2021-2031

The growing demand for better cardiovascular healthcare has been recognized as a key factor encouraging the growth of the global coronary stent market. The market is poised to witness a soaring success in the coming few years as high levels of scientific innovations brought into a range of coronary stents. At the same time, the market has also become more competitive due to an influx of products and establishment of several new players. Thus, the affordable pricing of coronary stents is also offering businesses in the global coronary stent market a new lease of life.

Besides competitive pricing, players are also offering products that promise utmost safety, efficacy, quality, and an effective outcome. As companies comply with set standards of quality, they are well-positioned to remain in power over the forecast period. The various products available in the global coronary stent market are drug-eluting stents, bio-absorbable stents, and bare-metal stents. Out of these, analysts predict that bio-absorbable stents are likely to gain significant momentum as they are known to improve abnormal endothelial function, restore normal vasomotion, and reduce the risk of inflammation and thrombosis.

Read more : https://www.tmrresearch.com/coronary-stent-market

Get Brochure : https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2051

[delicatemagazinedreamer]

When Should Bioresorbable Vascular Scaffold Be Used?

The invention of the drug-eluting stent (DES) was a watershed moment in the percutaneous treatment of coronary artery disease. To reduce the high rate of target lesion revascularization associated with balloon angioplasty and bare metal stents, the DES overcomes vessel recoil and restenosis. Despite these advantages, the DES is associated with an ongoing risk of stent-related complications due to permanent implantation of a foreign body and restriction of vascular vasomotion.

The Absorb Bioresorbable Vascular Scaffold Market was discontinued due to low demand. The available preclinical and clinical data for BRS to understand how vascular biological reactions to these devices differ from biological reactions to metallic drug-eluting stents, and how these responses translate into clinical outcomes. We also talk about next-generation BRS and outline the changes that need to be made to improve long-term outcomes with these devices so that they can eventually be a viable option for patients with symptomatic obstructive coronary artery disease.

Read more @ https://digitalgrowinfo.blogspot.com/2022/07/the-objective-of-bioresorbable-vascular.html

[industry365]

Coronary Stent Market Is Expected To Reach New Growth Revenues During 2021-2028

The global coronary stent market size is expected to reach USD 15.28 billion by 2027 according to a new study by Polaris Market Research. The report “Coronary Stent Market Share, Size, Trends, Industry Analysis Report, By Product (Drug Eluting, Bioresorbable Vascular Scaffold, Bare Metal Stents); By Metal (Cobalt Chromium, Platinum Chromium, Nickel Titanium, and Stainless Steel); By End Use (Hospitals, Ambulatory Surgical Centers, and Cardiology Centers); By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global Coronary Stent Market offers prominent opportunities for the players to flourish in the untapped low-income countries, particularly in the Asia Pacific region. Market is characterized by intense competition, flooded with many local players that develop safe, cost-effective, easy to use, and widely available products. These players adopt innovative strategies and develop full proof devices to provide product differentiation.

Cath labs or cardiac catheterization laboratories in hospitals and ambulance conduct both diagnostic and therapeutic procedures. For example, The Frankel Cardiovascular Center, has 4 cardiac catheterization laboratory that are used for coronary procedures, these labs complement two hybrid operating rooms. These medical facilities use technologically advanced such as DES, BMS and Bioresorbable Vascular Scaffold stents to improve the quality of life, offer better patient healthcare benefits like efficacy and safety profile, and minimize hospital stays. These procedures are not complex and are mostly performed in ASCs and digital cath labs. For Example, Absorb GT1 has clinically proven that the artery is able to dilate and contract, called vasomotion that is similar to healthy blood vessels.

Download sample: https://www.polarismarketresearch.com/industry-analysis/coronary-stent-market/request-for-sample

The incidence of CVDs is on the rise in globally. This is due to the lifestyle changes such as smoking and alcohol over consumption, un-healthy food habits, and lack of physical inactivity. These factors cause obesity, heart related ailments and diabetes that can lead to CVDs. In 2015, according to Global prevalence of Diabetes, India is seeing increasing diabetic patients which accounts for more than 62 million diabetic patients.

To treat this growing cases of CVDs, players are using advanced technologies to develop innovative products such as Bioresorbable Vascular Scaffold and nano-coated stents. Improvement in healthcare infrastructure has allowed medical facilities to adopt these advanced systems for disease treatment in spite of its cost. This will lead many people to undergo stent procedure to treat cardiac disorders. Public awareness of this procedure and associated systems and benefits will further lead many people to undergo them.

Market participants such as Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik, Terumo Corporation, Shandong JW Medical Systems, Cook Medicals, Biosensors International Group (acquired by Blue Sail Medical Co., Ltd), Stentys SA, B. Braun Melsungen AG, Liaoning Biomedical Materials, Meril Life Sciences, MicroPort Scientific Corporation, Lepu Medicals, Vascular Concepts, and Translumina GmbH are some of the key players operating in the concerned market.

For instance, in July, 2020, Blue Sail Medical Co., Ltd established its new Blue Sail Shanghai Innovation Center (BSIC), which was built after months of rigorous effort and well equipped with GMP facilities. The company entered into cardio-vascular area after acquiring Biosensors International Group. BSIC’s focus would be co-operating with the research and development based in Germany and Singapore to develop innovative coronary intervention products including stent from scratch.

Get Discount offer: https://www.polarismarketresearch.com/industry-analysis/coronary-stent-market/request-for-discount-pricing

Polaris Market research has segmented the Coronary Stent Market report on the basis of product, metal, end-use and region

Coronary Stent Product Outlook (Revenue – USD Million, 2016 – 2027)

Drug Eluting Stent

Bioresorbable Vascular Scaffold Stent

Bare Metal Stents

Coronary Stent Metal Outlook (Revenue – USD Million, 2016 – 2027)

Cobalt Chromium

Platinum Chromium

Nickel Titanium

Stainless Steel

Coronary Stent End-Use Outlook (Revenue – USD Million, 2016 – 2027)

Hospitals

Ambulatory Surgical Centers

Cardiology Centers

Coronary Stent Regional Outlook (Revenue – USD Million, 2016 – 2027)

North America

Europe

Asia Pacific

Central & South America

Middle East & Africa

U.S.

Canada

France

Germany

UK

Italy

Spain

Netherlands

Austria

China

India

Japan

Malaysia

South Korea

Indonesia

Mexico

Brazil

Argentina

UAE

Saudi Arabia

Israel

South Africa

Buy Now: https://www.polarismarketresearch.com/checkouts/6681

[karishmamulani]

Coronary Stent Market Analysis, Growth Forecast And Upcoming Trends Opportunities

The global coronary stent market size is expected to reach USD 15.28 billion by 2027 according to a new study by Polaris Market Research. The report “Coronary Stent Market Share, Size, Trends, Industry Analysis Report, By Product (Drug Eluting, Bioresorbable Vascular Scaffold, Bare Metal Stents); By Metal (Cobalt Chromium, Platinum Chromium, Nickel Titanium, and Stainless Steel); By End Use (Hospitals, Ambulatory Surgical Centers, and Cardiology Centers); By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global Coronary Stent Market offers prominent opportunities for the players to flourish in the untapped low-income countries, particularly in the Asia Pacific region. Market is characterized by intense competition, flooded with many local players that develop safe, cost-effective, easy to use, and widely available products. These players adopt innovative strategies and develop full proof devices to provide product differentiation.

Cath labs or cardiac catheterization laboratories in hospitals and ambulance conduct both diagnostic and therapeutic procedures. For example, The Frankel Cardiovascular Center, has 4 cardiac catheterization laboratory that are used for coronary procedures, these labs complement two hybrid operating rooms. These medical facilities use technologically advanced such as DES, BMS and Bioresorbable Vascular Scaffold stents to improve the quality of life, offer better patient healthcare benefits like efficacy and safety profile, and minimize hospital stays. These procedures are not complex and are mostly performed in ASCs and digital cath labs. For Example, Absorb GT1 has clinically proven that the artery is able to dilate and contract, called vasomotion that is similar to healthy blood vessels.

Request A Sample Copy At: https://www.polarismarketresearch.com/industry-analysis/coronary-stent-market/request-for-sample

The incidence of CVDs is on the rise in globally. This is due to the lifestyle changes such as smoking and alcohol over consumption, un-healthy food habits, and lack of physical inactivity. These factors cause obesity, heart related ailments and diabetes that can lead to CVDs. In 2015, according to Global prevalence of Diabetes, India is seeing increasing diabetic patients which accounts for more than 62 million diabetic patients.

To treat this growing cases of CVDs, players are using advanced technologies to develop innovative products such as Bioresorbable Vascular Scaffold and nano-coated stents. Improvement in healthcare infrastructure has allowed medical facilities to adopt these advanced systems for disease treatment in spite of its cost. This will lead many people to undergo stent procedure to treat cardiac disorders. Public awareness of this procedure and associated systems and benefits will further lead many people to undergo them.

Market participants such as Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik, Terumo Corporation, Shandong JW Medical Systems, Cook Medicals, Biosensors International Group (acquired by Blue Sail Medical Co., Ltd), Stentys SA, B. Braun Melsungen AG, Liaoning Biomedical Materials, Meril Life Sciences, MicroPort Scientific Corporation, Lepu Medicals, Vascular Concepts, and Translumina GmbH are some of the key players operating in the concerned market.

To get Incredible Discounts on this Premium Report, Click At : https://www.polarismarketresearch.com/industry-analysis/coronary-stent-market/request-for-discount-pricing

For instance, in July, 2020, Blue Sail Medical Co., Ltd established its new Blue Sail Shanghai Innovation Center (BSIC), which was built after months of rigorous effort and well equipped with GMP facilities. The company entered into cardio-vascular area after acquiring Biosensors International Group. BSIC’s focus would be co-operating with the research and development based in Germany and Singapore to develop innovative coronary intervention products including stent from scratch.

[moleculardepot]

Ischemia and No Obstructive Coronary Artery Disease: Prevalence and Correlates of Coronary Vasomotion Disorders. A new interesting article has been published in Circ Cardiovasc Interv. 2019 Dec; 12(12):e008126. doi: 10.1161/CIRCINTERVENTIONS.119.008126. Epub 2019 Dec 13.

[healthtimetaylor]

Effect of paeonol on blood pressure and blood flow in artery of spontaneously hypertensive rats and its mechanisms related on vasomotion.

PMID:  Zhongguo Zhong Yao Za Zhi. 2015 Dec ;40(24):4903-7. PMID: 27245041 Abstract Title:  [Effect of paeonol on blood pressure and blood flow in artery of spontaneously hypertensive rats and its mechanisms related on vasomotion]. Abstract:  Previous studies have shown that paeonol can antagonize acute myocardial ischemia and infarction in rat. This study further researched the effects of paeonol on blood pressure and blood flow in the artery of spontaneously hypertensive rats and its mechanisms related on vasomotion. Firstly, thirty spontaneously hypertensive rats were randomly divided into spontaneously hypertensive control group and paeonol-treating groups of high dose and low dose, and also, the other ten Wistar rats as healthy control group. Before and after the intraduodenal administration of the drug, arterial blood pressure was measured by carotid artery and blood flow through the renal artery and carotid artery in vivo were measured by animal flowmeter. The same volume of solvent was given to the spontaneously hypertensive control group and the healthy control group, and the other operations were same. In order to further study the effect of paeonol on vasomotor function, the superior mesenteric artery, renal artery and coronary artery of the spontaneously hypertensive rat were removed and separated, precontracted by a certain concentration of potassium chloride (KCl) and 5-serotonin (5-HT) respectively, and dilatory responses were assessed by cumulative addition of paeonol. Results showed that after duodenal one-time delivery of paeonol, the blood pressure significantly lowered, the renal arterial blood flow and the carotid arterial blood flow significantly increased in spontaneously hypertensive rat. And also, paeonol relaxed the mesenteric artery, renal artery and the coronary artery of spontaneously hypertensive rat in a concentration-dependent manner. These results indicated that the effect of paeonol on decreasing arterial blood pressure and increasing the arterial blood flow was related to its vasodilative effect.

read more

[itscalvinwilliams]

Bioabsorbable Stents market 2025- Boston Scientific Corporation, Kyoto Medical Planning, and Abbott

The global bioabsorbable stents market is expected to grow at growth rate of 10.8% to reach USD 469.8 million by 2025.

The bioabsorbable stent is a medical device, used in the interventional management of coronary artery disorder. This therapeutic modality is considered to be the next step in stent evolution and presents a novel approach in the treatment and management of heart disorders. The bioabsorbable stent is made of polylactide and is designed to restore blood flow to the heart. It offers a faster degradation rate and absorbed in the body with minimal or no complications. This product provides temporal support to the vessel before being reabsorbed or degraded by the body, promoting restoration of vasomotion and vessel healing. Due to this fact, research activities to develop new stents based on bioresorbable scaffold technologies is increasing over the last couple of years.

This bioabsorbable vascular scaffold offers a new and effective approach for the treatment of coronary artery disease. Rising incidences of cardiovascular disorders are expected to boost the demand for this product globally. According to the World Health Organizations (WHO), cardiovascular disorder is one of the leading cause of death worldwide. Such factors would, in turn, boost the demand for this product, driving the industry growth. Other factors such as favorable government initiatives, technological advancements and rising number of companies investing in this market support the industry growth. On contrary, recent trial results for ABSORB III study and first bioabsorbable sent being pulled off the market in September 2017 has slow down the growth of this industry to some extent. In addition, the cost this product is almost twice as compared to the other drug-eluting stents which is one of the restraining factors for this market.

Top Key Players Covered in this report – Boston Scientific Corporation, Kyoto Medical Planning, and Abbott

Get a Sample PDF Report:https://www.analystviewmarketinsights.com/request_sample/av135

By the Material, the market is primarily split into:S

Polymeric Stents Metallic Stents By the Application, the market is primarily split into:

Coronary Artery Disease Peripheral Artery Disease By the End Use, the market is primarily split into:RS

Hospitals Cardiac Care

The research study includes in-depth analysis where important segments and regional outlook are studied in quite some detail. It also includes market channel, distribute, and customer analysis, industry cost analysis, organization profiles, market analysis by application, production, revenue, and price trend analysis by type, production and consumption analysis by region, and various other market studies.

The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, Asia Pacific, Latin America and Middle East and Africa after evaluating political, economic, social and technological factors for the Bioabsorbable Stents market.

Points Covered in Worldwide Bioabsorbable Stents Industry Research Report:

The size of Bioabsorbable Stents industry in 2019 and its growth in 2025.

Factors which may influence Bioabsorbable Stents market strength of competition

The performance rate of Bioabsorbable Stents market in previous few years.

List of major competitors and their role in revenue growth

The change in value of because of numerous manufacturing brands.

Long-lasting and defects of the industry

For More Details On this Report: @ https://www.analystviewmarketinsights.com/report-highlight-bioabsorbable-stents-market-135

There are 11 Chapters to totally presentation the Bioabsorbable Stents market:

Chapter 1 and 2, to describe Bioabsorbable Stents Market Introduction, study scope, industry overview, market snippet, by segments and geographies and competitive insights

Chapter 3 and 4, to display the Porter’s, market strategy analysis, market sales channel, distributors, traders, dealers, market dynamics such as drivers, restraints opportunities, and market risk;

Chapter 5, to analyse the top manufacturers of Bioabsorbable Stents Market, with sales, industry share, in 2018 and 2019 and key innovators;

Chapter 6, 7 and 8 to study the market segments, estimates, forecast and YOY growth rate of individual segments from 2019 to 2025 along with the detailed qualitative analysis

Chapter 9, to show the global market by regions, with sales, revenue and market share of Bioabsorbable Stents Market, for each region and countries, from 2014 to 2025;

Chapter 10, to analyse key manufacturers, their sales revenue, business strategies, market expansion, key developments and industry share for 2018 or 2019;

Chapter 11 to describe Bioabsorbable Stents Research Findings and Conclusion, appendix and data source.

Buy Full Report @ https://www.analystviewmarketinsights.com/product/bioabsorbable-stents-market-135

If you don’t find that you are looking in this report so, please get in touch with our custom research team at sales@analystviewmarketinsights.com

[lilywhiteflower-blog]

Coronary Stent Market - Current Outlook Of Industry & Forecast 2017-2025

Global Coronary Stent Market: Snapshot

Coronary stents are medical devices primarily used in the treatment of coronary heart diseases by maintaining vessel patency. Their advent and continual device advancements have paved a new paradigm in cardiovascular care world over, especially in developing and developed nations. Their usage have particularly transformed the area of percutaneous coronary intervention in developing and developed nations. The market for coronary stents has progressed considerably over the recent decade from bare-metal stents to innovative stents such as bio-resorbable and drug-eluting types. Some of the key features influencing the efficacy of coronary stents are good biocompatibility, low thrombogenesis, good flexibility, and deliverability. Apart from this, some of the advanced coronary stents are made of alloys, notably of cobalt-chrome, to impart marked radial strength and radio-opacity. Various materials used for making coronary stents impart specific properties and help in fulfilling the required objective. For instance, a major number of self-expandable stents are made using nickel titanium, which imparts them the flexibility to retain shape when placed inside the vessel.

Over the years, the device has witnessed several enhancements, particularly design innovations. These are made possible by a growing number of clinical research organizations (CROs) intensively evaluating the efficacy and the comfort of the product. This has also accelerated product approvals in various developing and developed regions. The incorporation of polymer-free or bio-resorbable stents has helped in reducing the inflammatory effect of polymers used in previous generation of coronary stents. Polymer-free stents are considered as an advanced version of drug-eluting types since they potentially reduce the rate of stent thrombosis. The market is also witnessing substantial demand for partially-bioresorbable stents. However, the polymer left off in the vessel can be still be a cause for clinical concern. Advances in bioresorbable materials for making coronary stents are unlocking promising prospects in the global market.

Request Sample Copy of the Report @

https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2051

Global Coronary Stent Market: Overview

The alarming rise in the number of cardiovascular diseases has become the primary growth driver for the global coronary stent market. Changing lifestyles that are characterized by high stress levels, alcohol consumption, smoking, and poor choice of food habits have collectively led to questionable heart health for the global market. The World Health Organization states that the cardiovascular diseases have become the leading cause of deaths across the globe. As this problem aggravates, the global coronary stent market is projected to see a terrific growth rate between the forecast period of 2017 and 2025.

Global Coronary Stent Market: Key Trends

The growing demand for better cardiovascular healthcare has been recognized as a key factor encouraging the growth of the global coronary stent market. The market is poised to witness a soaring success in the coming few years as high levels of scientific innovations brought into a range of coronary stents. At the same time, the market has also become more competitive due to an influx of products and establishment of several new players. Thus, the affordable pricing of coronary stents is also offering businesses in the global coronary stent market a new lease of life.

Besides competitive pricing, players are also offering products that promise utmost safety, efficacy, quality, and an effective outcome. As companies comply with set standards of quality, they are well-positioned to remain in power over the forecast period. The various products available in the global coronary stent market are drug-eluting stents, bio-absorbable stents, and bare-metal stents. Out of these, analysts predict that bio-absorbable stents are likely to gain significant momentum as they are known to improve abnormal endothelial function, restore normal vasomotion, and reduce the risk of inflammation and thrombosis.

Request TOC of the Report @

https://www.tmrresearch.com/sample/sample?flag=T&rep_id=2051

Global Coronary Stent Market: Market Potential

The supportive stance of the U.S. Food and Drug Administration (FDA) has accelerated the production of innovative coronary stents in the past few years. For instance, CeloNova Biosciences, Inc. recently received an approval from the U.S. FDA for its COBRA PzF™ NanoCoated Coronary Stent System, the first of its kind. The stent has a biocompatible proprietary nanothin polymer coating, which needs a month of dual antiplatelet therapy regimen post surgery. The new stent has been designed to better the coronary luminal diameter. It is expected to benefit patients suffering from symptomatic ischemic heart disease, which will also include diabetic patients with heart diseases. Thus, the efforts to launch effective products that better the quality of life along with support from regulatory authorities are expected to favor market growth in the near future.

Global Coronary Stent Market: Regional Outlook

In terms of geography, the global coronary stent market is segmented into North America, Asia Pacific, Europe, the Middle East and Africa, and Latin America. Of these, North America coronary stent market is expected to hold a dominant share in the overall market as the region has a well-established healthcare infrastructure. Increasing investments in research and development of medical devices and higher acceptance of latest technologies have collectively aided this regional market’s lead in the global market.

Analysts expect Asia Pacific to be instrumental to the rise of the global coronary stent market in the coming years. With a huge population base, Asia Pacific is likely to offer lucrative opportunities for the uptake of coronary stents in the near future. Furthermore, the budding medical tourism industry in the emerging economies of Asia Pacific are also expected to drive the coronary stent market in the region over the forecast period.

Key Players Mentioned in this Report are:

Some of the leading players operating in the global coronary stent market are TERUMO CORPORATION, Medtronic plc, Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, Abbott Laboratories, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, STENTYS SA, B. Braun Melsungen AG, MicroPort Scientific Corporation, Translumina GmbH, and Vascular Concepts.

Read Comprehensive Overview of Report @

https://www.tmrresearch.com/coronary-stent-market

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Email: sales@tmrresearch.com

[priyankaganguly-blog]

Coronary Stent Market - Highlights On Product Need 2025

Global Coronary Stent Market: Snapshot

Coronary stents are medical devices primarily used in the treatment of coronary heart diseases by maintaining vessel patency. Their advent and continual device advancements have paved a new paradigm in cardiovascular care world over, especially in developing and developed nations. Their usage have particularly transformed the area of percutaneous coronary intervention in developing and developed nations. The market for coronary stents has progressed considerably over the recent decade from bare-metal stents to innovative stents such as bio-resorbable and drug-eluting types. Some of the key features influencing the efficacy of coronary stents are good biocompatibility, low thrombogenesis, good flexibility, and deliverability. Apart from this, some of the advanced coronary stents are made of alloys, notably of cobalt-chrome, to impart marked radial strength and radio-opacity. Various materials used for making coronary stents impart specific properties and help in fulfilling the required objective. For instance, a major number of self-expandable stents are made using nickel titanium, which imparts them the flexibility to retain shape when placed inside the vessel.

Request Sample Copy of the Report @

https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2051

Over the years, the device has witnessed several enhancements, particularly design innovations. These are made possible by a growing number of clinical research organizations (CROs) intensively evaluating the efficacy and the comfort of the product. This has also accelerated product approvals in various developing and developed regions. The incorporation of polymer-free or bio-resorbable stents has helped in reducing the inflammatory effect of polymers used in previous generation of coronary stents. Polymer-free stents are considered as an advanced version of drug-eluting types since they potentially reduce the rate of stent thrombosis. The market is also witnessing substantial demand for partially-bioresorbable stents. However, the polymer left off in the vessel can be still be a cause for clinical concern. Advances in bioresorbable materials for making coronary stents are unlocking promising prospects in the global market.

Global Coronary Stent Market: Overview

The alarming rise in the number of cardiovascular diseases has become the primary growth driver for the global coronary stent market. Changing lifestyles that are characterized by high stress levels, alcohol consumption, smoking, and poor choice of food habits have collectively led to questionable heart health for the global market. The World Health Organization states that the cardiovascular diseases have become the leading cause of deaths across the globe. As this problem aggravates, the global coronary stent market is projected to see a terrific growth rate between the forecast period of 2017 and 2025. 

Global Coronary Stent Market: Key Trends

The growing demand for better cardiovascular healthcare has been recognized as a key factor encouraging the growth of the global coronary stent market. The market is poised to witness a soaring success in the coming few years as high levels of scientific innovations brought into a range of coronary stents. At the same time, the market has also become more competitive due to an influx of products and establishment of several new players. Thus, the affordable pricing of coronary stents is also offering businesses in the global coronary stent market a new lease of life.

Request TOC of the Report @

https://www.tmrresearch.com/sample/sample?flag=T&rep_id=2051

Besides competitive pricing, players are also offering products that promise utmost safety, efficacy, quality, and an effective outcome. As companies comply with set standards of quality, they are well-positioned to remain in power over the forecast period. The various products available in the global coronary stent market are drug-eluting stents, bio-absorbable stents, and bare-metal stents. Out of these, analysts predict that bio-absorbable stents are likely to gain significant momentum as they are known to improve abnormal endothelial function, restore normal vasomotion, and reduce the risk of inflammation and thrombosis. 

Global Coronary Stent Market: Market Potential

The supportive stance of the U.S. Food and Drug Administration (FDA) has accelerated the production of innovative coronary stents in the past few years. For instance, CeloNova Biosciences, Inc. recently received an approval from the U.S. FDA for its COBRA PzF™ NanoCoated Coronary Stent System, the first of its kind. The stent has a biocompatible proprietary nanothin polymer coating, which needs a month of dual antiplatelet therapy regimen post surgery. The new stent has been designed to better the coronary luminal diameter. It is expected to benefit patients suffering from symptomatic ischemic heart disease, which will also include diabetic patients with heart diseases. Thus, the efforts to launch effective products that better the quality of life along with support from regulatory authorities are expected to favor market growth in the near future. 

Global Coronary Stent Market: Regional Outlook

In terms of geography, the global coronary stent market is segmented into North America, Asia Pacific, Europe, the Middle East and Africa, and Latin America. Of these, North America coronary stent market is expected to hold a dominant share in the overall market as the region has a well-established healthcare infrastructure. Increasing investments in research and development of medical devices and higher acceptance of latest technologies have collectively aided this regional market’s lead in the global market. 

Read Comprehensive Overview of Report @

https://www.tmrresearch.com/coronary-stent-market

Analysts expect Asia Pacific to be instrumental to the rise of the global coronary stent market in the coming years. With a huge population base, Asia Pacific is likely to offer lucrative opportunities for the uptake of coronary stents in the near future. Furthermore, the budding medical tourism industry in the emerging economies of Asia Pacific are also expected to drive the coronary stent market in the region over the forecast period. 

Key Players Mentioned in this Report are:

Some of the leading players operating in the global coronary stent market are TERUMO CORPORATION, Medtronic plc, Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, Abbott Laboratories, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, STENTYS SA, B. Braun Melsungen AG, MicroPort Scientific Corporation, Translumina GmbH, and Vascular Concepts. 

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Email: sales@tmrresearch.com

[healthywealthywiselife]

Eating Chocolate for Diabetes?

Did Someone Say Chocolate?

Well, not Hersey's milk chocolate. A group studying cocoa has found components within the main ingredient of chocolate that helps release more insulin and respond to increases in blood glucose more efficiently.1 This is not the first time that cocoa has been championed as a health food. Dark chocolate has long been known to help lower blood pressure, through its vasodilative abilities, as well as decrease platelet adhesion.2 Of course, it's not the cheap stuff, but the $4 bar of dark chocolate, with the 85% cocoa, that is on the brink of being too bitter for most people, that we're talking about.

Epicatechin Monomers Seem to Protect Beta Cells, Specifically Mitochondria

Epicatechin monomers, which are found in cocoa, have been shown to increase the strength of beta cells in the pancreas the beta cells are what produces insulin, in response to increases in blood glucose. Epicatechin monomers seem to be protecting the beta cells, specifically the mitochondria by increasing their resilience to oxidative stress. The increase, or protection of mitochondrial function equates to more ATP being produced, and thereby sustained (appropriate) insulin release.

Dark Chocolate May be a Healthy Dessert Choice with Myriad Benefits

The scientists first noted that cocoa was a favorable agent in diabetes by feeding it to animals on a high-fat diet. The cocoa seemed to give the animals more resilience to the high fat diet. They then looked deeper into the mechanism and found the epicatechins to be the likely mechanism. Of course, chocolate is not being advocated as a treatment for diabetes. The amount of cocoa that would need to be eaten is likely to outweigh the benefits, especially if it has sugar, dairy, and other undesirable preservatives added. However, dark chocolate may be a reasonable healthy dessert choice which will also have benefits. As part of other lifestyle and dietary changes, perhaps it could play its part in supporting pancreatic function.

Sources:

Source

Flammer AJ, Hermann F, Sudano I, et al. Dark chocolate improves coronary vasomotion and reduces platelet reactivity. Circulation. 2007;116(21):2376-82.

ImageCopyright: